R.s. Surgipharm Private Limited — Bevacizumab Exporter Profile
Indian Pharmaceutical Exporter · #12 for Bevacizumab · $214.1K export value · DGFT Verified
R.s. Surgipharm Private Limited is the #12 Indian exporter of Bevacizumab with $214.1K in export value and 71 verified shipments. R.s. Surgipharm Private Limited holds a 0.5% market share in Bevacizumab exports across 2 countries. The company exports 7 pharmaceutical products worth $431.6K across 2 therapeutic categories.
R.s. Surgipharm Private Limited — Bevacizumab Export Profile: Buyers & Destinations
Where Does R.s. Surgipharm Private Limited Export Bevacizumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $212.7K | 68 | 99.3% |
| CAMEROON | $1.4K | 3 | 0.7% |
R.s. Surgipharm Private Limited exports Bevacizumab to 2 countries. The largest destination is KENYA accounting for 99.3% of R.s. Surgipharm Private Limited's Bevacizumab shipments. These destinations reflect R.s. Surgipharm Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bevacizumab from India?
| Buyer |
|---|